These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 25837163)

  • 1. Expression of sarcosine metabolism-related proteins in invasive lobular carcinoma: comparison to invasive ductal carcinoma.
    Cha YJ; Jung WH; Cho NH; Koo JS
    Yonsei Med J; 2015 May; 56(3):598-607. PubMed ID: 25837163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Lipid Metabolism-Related Proteins Differs between Invasive Lobular Carcinoma and Invasive Ductal Carcinoma.
    Cha YJ; Kim HM; Koo JS
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28124996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of autophagy related proteins in invasive lobular carcinoma: comparison to invasive ductal carcinoma.
    Cha YJ; Kim YH; Cho NH; Koo JS
    Int J Clin Exp Pathol; 2014; 7(6):3389-98. PubMed ID: 25031766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of sarcosine metabolism-related proteins in estrogen receptor negative breast cancer according to the androgen receptor and HER-2 status.
    Kim MJ; Jung WH; Koo JS
    Int J Clin Exp Pathol; 2015; 8(7):7967-77. PubMed ID: 26339363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of DNA methylation-related proteins in invasive lobular carcinoma of breast: comparison to invasive ductal carcinoma.
    Cha YJ; Kim HM; Koo JS
    Histol Histopathol; 2017 Nov; 32(11):1175-1185. PubMed ID: 28111737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of metabolism-related proteins in invasive lobular carcinoma: comparison to invasive ductal carcinoma.
    Kim YH; Jung WH; Koo JS
    Tumour Biol; 2014 Oct; 35(10):10381-93. PubMed ID: 25053597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative effectiveness of adjuvant chemotherapy for invasive lobular compared with invasive ductal carcinoma of the breast.
    Marmor S; Hui JYC; Huang JL; Kizy S; Beckwith H; Blaes AH; Rueth NM; Tuttle TM
    Cancer; 2017 Aug; 123(16):3015-3021. PubMed ID: 28382636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis.
    Turashvili G; Bouchal J; Baumforth K; Wei W; Dziechciarkova M; Ehrmann J; Klein J; Fridman E; Skarda J; Srovnal J; Hajduch M; Murray P; Kolar Z
    BMC Cancer; 2007 Mar; 7():55. PubMed ID: 17389037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the clinicopathological features of invasive ductal, invasive lobular, and mixed (invasive ductal + invasive lobular) carcinoma of the breast.
    Zengel B; Yararbas U; Duran A; Uslu A; Elıyatkın N; Demırkıran MA; Cengiz F; Şimşek C; Postacı H; Vardar E; Durusoy R
    Breast Cancer; 2015 Jul; 22(4):374-81. PubMed ID: 23925582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of CD151/integrin α3β1 complex is predictive of poor outcome in node-negative lobular breast carcinoma: opposing roles of CD151 in invasive lobular and ductal breast cancers.
    Romanska HM; Potemski P; Krakowska M; Mieszkowska M; Chaudhri S; Kordek R; Kubiak R; Speirs V; Hanby AM; Sadej R; Berditchevski F
    Br J Cancer; 2015 Nov; 113(9):1350-7. PubMed ID: 26418423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of sarcosine metabolism-related proteins according to metastatic site in breast cancer.
    Cha YJ; Kim DH; Jung WH; Koo JS
    Int J Clin Exp Pathol; 2014; 7(11):7824-33. PubMed ID: 25550822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival analysis in patients with invasive lobular cancer and invasive ductal cancer according to hormone receptor expression status in the Korean population.
    Kwon D; Ko BK; Jung SP; Kim HK; Kim EK; Jung YS; Youn HJ; Lee SB
    PLoS One; 2022; 17(1):e0262709. PubMed ID: 35051228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mixed Invasive Ductal and Lobular Carcinoma of the Breast: Prognosis and the Importance of Histologic Grade.
    Metzger-Filho O; Ferreira AR; Jeselsohn R; Barry WT; Dillon DA; Brock JE; Vaz-Luis I; Hughes ME; Winer EP; Lin NU
    Oncologist; 2019 Jul; 24(7):e441-e449. PubMed ID: 30518616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of cancer-associated fibroblast-related proteins differs between invasive lobular carcinoma and invasive ductal carcinoma.
    Park CK; Jung WH; Koo JS
    Breast Cancer Res Treat; 2016 Aug; 159(1):55-69. PubMed ID: 27469595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Long-term Study of a Large Series of Patients with Invasive Ductal Carcinoma and Invasive Lobular Carcinoma. Loco-Regional Recurrence, Metastasis, and Survival.
    García-Fernández A; Lain JM; Chabrera C; García Font M; Fraile M; Barco I; Torras M; Reñe A; González S; González C; Piqueras M; Veloso E; Cirera L; Pessarrodona A; Giménez N
    Breast J; 2015; 21(5):533-7. PubMed ID: 26190560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma.
    Adachi Y; Ishiguro J; Kotani H; Hisada T; Ichikawa M; Gondo N; Yoshimura A; Kondo N; Hattori M; Sawaki M; Fujita T; Kikumori T; Yatabe Y; Kodera Y; Iwata H
    BMC Cancer; 2016 Mar; 16():248. PubMed ID: 27015895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mixed invasive ductal and lobular carcinoma has distinct clinical features and predicts worse prognosis when stratified by estrogen receptor status.
    Xiao Y; Ma D; Ruan M; Zhao S; Liu XY; Jiang YZ; Shao ZM
    Sci Rep; 2017 Sep; 7(1):10380. PubMed ID: 28871133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of differences in expression of sarcosine metabolism-related proteins according to the molecular subtype of breast cancer.
    Yoon JK; Kim DH; Koo JS
    J Transl Med; 2014 May; 12():149. PubMed ID: 24884785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in Response and Surgical Management with Neoadjuvant Chemotherapy in Invasive Lobular Versus Ductal Breast Cancer.
    Truin W; Vugts G; Roumen RM; Maaskant-Braat AJ; Nieuwenhuijzen GA; van der Heiden-van der Loo M; Tjan-Heijnen VC; Voogd AC
    Ann Surg Oncol; 2016 Jan; 23(1):51-7. PubMed ID: 25980321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of sentinel lymph node biopsy between invasive lobular carcinoma and invasive ductal carcinoma.
    Adachi Y; Sawaki M; Hattori M; Yoshimura A; Gondo N; Kotani H; Iwase M; Kataoka A; Onishi S; Sugino K; Terada M; Horisawa N; Mori M; Oze I; Iwata H
    Breast Cancer; 2018 Sep; 25(5):560-565. PubMed ID: 29536376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.